New Drug Actemra Up for FDA Approval

By Christine Miller, Health Guide Friday, November 30, 2007
After positive research results were presented at the American College of Rheumatology Annual Scientific Meeting earlier this month, Roche announced this week that it has filed for FDA approval of a biologics license application for its drug tocilizumab (marketed as Actemra) for the treatment of sign...
Anti-TNF Inhibitor Therapy May Provide Long Lasting Relief for RA: Study
12/19/08 8:40pm

I am involved with this study.  I have been receiving this medication for almost 2 years.  Back history:  I was diagnosed with JRA at 2 years old.  Remission from 6 till I was 26.  Since that point I have tried most medication combinations.  I have been medication resistant.  Research has been my only option for the last several years.  With this drug, I have a life again.  I can exercise.  I can tie my own shoes.  Pain isn't the first thing I think of when I wake up in the morning.  My only fear is when it does get FDA approval that it will be exorbitantly priced out of my budget.  Like most folks, I have insurance because I am disabled.  But of course when you look at your portion of the bill and it is still the price of a house payment (or rental in my case), it becomes an issue.  I can only hope that Roche has a program to assist those of us who don't have prescriptive programs that pay well to still get the med.  Otherwise I am back to the drawing board and on to another research drug and praying for no major slide back into inflammation and joint destruction.

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (3514) >
By Christine Miller, Health Guide— Last Modified: 06/28/11, First Published: 11/30/07